RR Cancer - Banque de la prostate - CRCHUM, Canada

Certification Status: Approved

Registration Status: Completed

Objective: Le RRCancer est un rÃ©seau provincial qui comprend un support pour pour les biobanques. La banque de donnÃ©es et de tissus (BTD) est une axe de ce rÃ©seau qui cible les tumeurs solides dont celles de la prostate. La biobanque en cancer de la prostate du CHUM fait parti des sites majeurs de collection en cancer de la prostate. Le matÃ©riel de la biobanque est mis ÃƒÂ la disposition des chercheurs du QuÃ©bec, mais aussi de l'extÃ©rieur selon des conditions spÃ©cifiques reliÃ©es ÃƒÂ l'Ã©thique et ÃƒÂ la mission du rÃ©seau

Registered Biobank Name	RR Cancer - Banque de la prostate - CRCHUM
Biobank Leader	VÃ©ronique Ouellet
Country	Canada
Email for biobank inquiries	ouelletv@gmail.com
Principal Investigator	Fred Saad
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).